Price range: $300.00 through $1,500.00

Ketamine HCL 200mg/ml Injectable is a high-concentration sterile injectable solution formulated for controlled clinical, laboratory, and professional environments. Each vial contains 200 milligrams of ketamine hydrochloride per milliliter, providing a total of 4,000 mg of active compound in a single 20 ml vial. Because of this concentrated formulation, healthcare professionals can prepare accurate doses while using smaller injection volumes when required.

Ketamine hydrochloride belongs to a class of medications known as dissociative anesthetics. Medical professionals have used this compound for decades due to its rapid onset of action and predictable pharmacological profile. Unlike many traditional anesthetic agents, ketamine primarily works by blocking NMDA receptors in the brain, producing dissociative anesthesia while often maintaining cardiovascular stability in controlled medical settings.

In addition, clinicians value ketamine for its unique pharmacological characteristics and versatility. The compound interacts with glutamate pathways within the central nervous system, which has made it an important subject of clinical research. As a result, researchers continue to study ketamine within controlled environments to better understand its neurological and pharmacological properties.

Key Product Specifications

Active Ingredient:
Ketamine Hydrochloride

Strength:
200 mg per ml

Total Active Content:
4,000 mg per vial

Volume:
20 ml sterile vial

Formulation:
Sterile aqueous injectable solution

Packaging:
Sealed pharmaceutical-grade glass vial

Professional Applications

Healthcare professionals commonly use ketamine hydrochloride in controlled medical environments, including anesthesia and clinical research settings. In most cases, trained professionals administer the injectable formulation intravenously (IV) or intramuscularly (IM) depending on the clinical protocol.

Furthermore, researchers continue to investigate ketamine because of its interaction with NMDA receptors and glutamate signaling pathways. These interactions make the compound particularly relevant in studies related to neurological and psychiatric conditions. However, trained professionals must supervise all administration and research applications to ensure proper safety and regulatory compliance.

Packaging and Storage

Manufacturers supply Ketamine HCL 200mg/ml Injectable in a secure sterile glass vial designed to maintain product stability and purity. Proper storage conditions help preserve the potency and effectiveness of the injectable solution.

Recommended storage guidelines include:

  • Store in a cool, dry environment
  • Protect the vial from direct light exposure
  • Keep the container sealed until use
  • Follow proper sterile handling procedures

Maintaining appropriate storage conditions helps ensure the injectable formulation retains its sterility, stability, and concentration accuracy over time.

Quality and Manufacturing Standards

Pharmaceutical manufacturers typically produce ketamine injectable solutions under strict quality-controlled conditions. These standards ensure consistent concentration, sterility, and purity in every vial produced.

In addition, quality control procedures verify that each batch meets established pharmaceutical standards before distribution. Because of these procedures, healthcare professionals and laboratories can rely on the product for consistent performance in regulated medical or research environments.

Important Notice

Ketamine hydrochloride is a regulated medication in many jurisdictions. Qualified professionals should handle and administer this product according to local laws, medical guidelines, and safety protocols. This formulation is intended strictly for authorized medical or research environments under professional supervision.

EnglishenEnglishEnglish